It’s welcome news, of course, that dexamethasone can reduce mortality in people with moderate to severe respiratory complications due to Covid-19. But to hail it as a big breakthrough – as the Health Secretary Matt Hancock did this week – is a step too far. Perhaps next week, Hancock will be shouting about the use of paracetamol as a treatment for headaches.
Already a subscriber? Log in
Black Friday sale
Subscribe today and get 10 weeks of The Spectator Australia for just $1
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Black Friday sale
Subscribe today and get 10 weeks of The Spectator Australia for just $1
SUBSCRIBEAlready a subscriber? Log in